Literature DB >> 22183029

Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease.

Olga Gornik1, Tamara Pavić, Gordan Lauc.   

Abstract

BACKGROUND: Nearly all membrane and secreted proteins, as well as numerous intracellular proteins are glycosylated. However, contrary to proteins which are defined by their individual genetic templates, glycans are encoded in a complex dynamic network of hundreds of genes which participate in the complex biosynthetic pathway of protein glycosylation. SCOPE OF REVIEW: This review summarizes present knowledge about the importance of alternative glycosylation of IgG and other proteins. MAJOR
CONCLUSIONS: Numerous proteins depend on correct glycosylation for proper function. Very good example for this is the alternative glycosylation of IgG whose effector functions can be completely changed by the addition or removal of a single monosaccharide residue from its glycans. GENERAL SIGNIFICANCE: The change in the structure of a protein requires mutations in DNA and subsequent selection in the next generation, while even slight alterations in activity or intracellular localization of one or more biosynthetic enzymes are sufficient for the creation of novel glycan structures, which can then perform new functions. Glycome composition varies significantly between individuals, which makes them slightly or even significantly different in their ability to execute specific molecular pathways with numerous implications for development and progression of various diseases. This article is part of a Special Issue entitled Glycoproteomics.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183029     DOI: 10.1016/j.bbagen.2011.12.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  45 in total

Review 1.  Genomics and epigenomics of the human glycome.

Authors:  Vlatka Zoldoš; Mislav Novokmet; Ivona Bečeheli; Gordan Lauc
Journal:  Glycoconj J       Date:  2012-05-31       Impact factor: 2.916

2.  A Markov chain model for N-linked protein glycosylation--towards a low-parameter tool for model-driven glycoengineering.

Authors:  Philipp N Spahn; Anders H Hansen; Henning G Hansen; Johnny Arnsdorf; Helene F Kildegaard; Nathan E Lewis
Journal:  Metab Eng       Date:  2015-10-29       Impact factor: 9.783

Review 3.  Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Ema Prenc; Drazen Pulanic; Maja Pucic-Bakovic; Marija Pezer; Lana Desnica; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Biochim Biophys Acta       Date:  2016-02-26

4.  Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.

Authors:  Mirna Šimurina; Noortje de Haan; Frano Vučković; Nicholas A Kennedy; Jerko Štambuk; David Falck; Irena Trbojević-Akmačić; Florent Clerc; Genadij Razdorov; Anna Khon; Anna Latiano; Renata D'Incà; Silvio Danese; Stephan Targan; Carol Landers; Marla Dubinsky; Dermot P B McGovern; Vito Annese; Manfred Wuhrer; Gordan Lauc
Journal:  Gastroenterology       Date:  2018-01-06       Impact factor: 22.682

Review 5.  Serum sialylation changes in cancer.

Authors:  Zejian Zhang; Manfred Wuhrer; Stephanie Holst
Journal:  Glycoconj J       Date:  2018-04-21       Impact factor: 2.916

6.  Glycosylation Profile of IgG in Moderate Kidney Dysfunction.

Authors:  Clara Barrios; Jonas Zierer; Ivan Gudelj; Jerko Štambuk; Ivo Ugrina; Eva Rodríguez; María José Soler; Tamara Pavić; Mirna Šimurina; Toma Keser; Maja Pučić-Baković; Massimo Mangino; Julio Pascual; Tim D Spector; Gordan Lauc; Cristina Menni
Journal:  J Am Soc Nephrol       Date:  2015-07-16       Impact factor: 10.121

7.  Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes.

Authors:  Toma Keser; Ivan Gornik; Frano Vučković; Najda Selak; Tamara Pavić; Edita Lukić; Ivan Gudelj; Hrvoje Gašparović; Bojan Biočina; Therese Tilin; Annika Wennerström; Satu Männistö; Veikko Salomaa; Aki Havulinna; Wei Wang; James F Wilson; Nish Chaturvedi; Markus Perola; Harry Campbell; Gordan Lauc; Olga Gornik
Journal:  Diabetologia       Date:  2017-09-13       Impact factor: 10.122

8.  Synthetic Glycopeptides Allow for the Quantitation of Scarce Nonfucosylated IgG Fc N-Glycans of Therapeutic Antibody.

Authors:  Kazuki Hammura; Akari Ishikawa; Ravi Kumar H V; Risho Miyoshi; Yasuhiro Yokoi; Masakazu Tanaka; Hiroshi Hinou; Shin-Ichiro Nishimura
Journal:  ACS Med Chem Lett       Date:  2018-08-10       Impact factor: 4.345

9.  The association between subclass-specific IgG Fc N-glycosylation profiles and hypertension in the Uygur, Kazak, Kirgiz, and Tajik populations.

Authors:  J N Liu; M Dolikun; J Štambuk; I Trbojević-Akmačić; J Zhang; H Wang; D Q Zheng; X Y Zhang; H L Peng; Z Y Zhao; D Liu; Y Sun; Q Sun; Q H Li; J X Zhang; M Sun; W J Cao; A Momčilović; G Razdorov; L J Wu; A Russell; Y X Wang; M S Song; G Lauc; W Wang
Journal:  J Hum Hypertens       Date:  2018-06-05       Impact factor: 3.012

10.  IgG Glycome in Colorectal Cancer.

Authors:  Frano Vučković; Evropi Theodoratou; Kujtim Thaçi; Maria Timofeeva; Aleksandar Vojta; Jerko Štambuk; Maja Pučić-Baković; Pauline M Rudd; Lovorka Đerek; Dražen Servis; Annika Wennerström; Susan M Farrington; Markus Perola; Yurii Aulchenko; Malcolm G Dunlop; Harry Campbell; Gordan Lauc
Journal:  Clin Cancer Res       Date:  2016-02-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.